U S Food and Drug Administration Home Page

- OTC benzocaine teething products pose serious risk
- FDA takes action to discontinue these products, add warnings to other OTC oral health products containing benzocaine
- OTC benzocaine teething products pose serious risk
- FDA finalizes guidance on menu labeling
- Menu labeling rule implemented on May 7, 2018 for restaurants and retail eating establishments
- FDA finalizes guidance on menu labeling
- FDA, FTC take action against e-liquid companies
- Companies misleadingly packaged, labeled e-liquids to resemble kid friendly food products such as juice boxes, candy, cereal
- FDA, FTC take action against e-liquid companies

Newsroom Meetings Testimonies Speeches

Newsroom

For Consumers
Updates and information for staying safe and healthy
For Patients
Learn about other treatments, drug/device approvals, public meetings and more
For Health Professionals
Medical product safety information, adverse event/problem reporting and more
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more
For Industry
Guidance, registration and listing, pay user fees, import programs and more

OTC benzocaine teething products pose serious risk